Detalhe da pesquisa
1.
Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med
; 389(24): 2245-2255, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091531
2.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320659
3.
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Ann Intern Med
; 177(2): 189-195, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190712
4.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis
; 78(3): 746-755, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972288
5.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
6.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043894
7.
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med
; 385(15): 1355-1371, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496194
8.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep
; 73(12): 271-276, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547037
9.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep
; 73(8): 168-174, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421935
10.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(8): 180-188, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421945
11.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis
; 228(2): 185-195, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683410
12.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
13.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis
; 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041853
14.
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.
Am J Epidemiol
; 192(2): 205-216, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193854
15.
COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion.
Am J Epidemiol
; 192(8): 1386-1395, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928091
16.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227984
17.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep
; 72(33): 886-892, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37590187
18.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
19.
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
J Infect Dis
; 226(3): 374-385, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668702
20.
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
N Engl J Med
; 390(12): 1156, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507772